INTECH Investment Management’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$686K Sell
17,062
-776
-4% -$33.4K 0.01% 1184
2025
Q4
$903K Buy
17,838
+424
+2% +$15.1K 0.01% 1184
2025
Q3
$506K Sell
17,414
-12,125
-41% -$280K ﹤0.01% 1573
2025
Q2
$696K Buy
29,539
+893
+3% +$20.1K 0.01% 1420
2025
Q1
$688K Buy
28,646
+11,576
+68% +$372K 0.01% 1436
2024
Q4
$722K Buy
17,070
+6,333
+59% +$280K 0.01% 1342
2024
Q3
$475K Buy
+10,737
New +$407K 0.01% 1254

Other funds holding VERA

INTECH Investment Management's VERA Position: Q1 2026 in Review

INTECH Investment Management reduced its Vera Therapeutics (VERA) stake by 4.4% in Q1 2026, selling an estimated $33.4K and leaving 17,062 shares worth $686K. The position accounts for 0.01% of the portfolio, ranked #1184.

INTECH Investment Management first reported a position in VERA in Q3 2024 and has held it in 7 quarters since. The position peaked at $903K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • INTECH Investment Management held 17,062 shares of Vera Therapeutics worth $686K as of Q1 2026.
  • INTECH Investment Management sold 776 Vera Therapeutics shares in Q1 2026, an estimated $33.4K.
  • Vera Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1184 holding.
  • INTECH Investment Management first reported a position in Vera Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Vera Therapeutics position peaked at $903K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.